Trial intelligence / Profile preview

Biodentine vs MTA in Direct Pulp Capping

NCT02803528Completed

Sponsor
Damascus University
Start
Jan 2015
Primary completion
Jan 2017
Modality
Small Molecules, Device-based Delivery
Countries
1
01

Overview

Trial of Biodentine in dental caries (2 arms), sponsored by Damascus University. Primary endpoint: Success of treatment following capping at 24 months. Started Jan 2015; status: completed.

02

Drugs

Biodentine
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT02803528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02803528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call